2023 Event Program

Icon Legend

This session is not on your agenda.

This session is on your agenda. Click again to remove it.

Presentation Icons

ACVIM Resident Research Award Eligible

Additional Fees May Be Required

By Invite Only

Capturing for On Demand

Cardiology Research Abstract Award Eligible

ERC Approved Lecture for ACVIM Residency

ePoster

Livestream

One Health

Pre-Registration Required

RACE-Approved

Research Abstract

Specialty Symposium

State-of-the-Art (SOTA) Presentation

Veterinary Technician

Type here to filter the list

On Demand
Demystifying IMRT and SRT
Primary Presenter: Michelle Turek, DVM, DACVIM (Oncology), DACVR (Radiation Oncology) (she/her/hers) – University of Wisconsin - Madison School of Veterinary Medicine
Oncology
CE: 1
On Demand
Identifying and Responding to Individual and Workplace Needs
Primary Presenter: Stephanie W. Johnson, LCSW (she/her/hers) – Louisiana State University School of Veterinary Medicine
Oncology
CE: 1
On Demand
Molecular Diagnostics in Oncology: Existing Technologies and Next Generation Tools
Primary Presenter: Heather Gardner, DVM, PhD, DACVIM (Oncology) – Cummings School of Veterinary Medicine-Tufts
Co-Presenter: Anne C. Avery, VMD, PhD – Colorado State University
Oncology
CE: 1
On Demand
The Drug Approval Process at FDA CVM with a Focus on Oncology Drugs
Primary Presenter: Christopher Loss, DVM (he/him/his) – FDA / Center for Veterinary Medicine
Oncology
CE: 1
Wednesday, Jun 14th
9:30 AM – 10:30 AM ET
The NCI DOG2 Project Overview: Contributions to Osteosarcoma Research
Location: PCC 108B
Primary Presenter: Amy K. LeBlanc, DVM, DACVIM (Oncology) – NIH/NCI/CCR Comparative Oncology Program
Oncology
Sponsored by
CE: 1
Wednesday, Jun 14th
10:45 AM – 11:45 AM ET
The NCI DOG2 Project: Updates and Future Directions
Location: PCC 108B
Primary Presenter: Amy K. LeBlanc, DVM, DACVIM (Oncology) – NIH/NCI/CCR Comparative Oncology Program
Oncology
Sponsored by
CE: 1
Wednesday, Jun 14th
11:45 AM – 1:15 PM ET
Oncology Specialty Networking Luncheon
Location: PCC 111AB
Oncology
Sponsored by
Wednesday, Jun 14th
1:30 PM – 2:30 PM ET
The Future of Immune Checkpoint Inhibition in Veterinary Oncology
Location: PCC 108B
Primary Presenter: David M. Vail, DVM, DACVIM (Oncology) (he/him/his) – University of Wisconsin-Madison
Co-Presenter: Laura M. Greene, DVM, DACVIM (SAIM) (she/her/hers) – Merck Animal Health
Oncology
Sponsored by
CE: 1
Wednesday, Jun 14th
2:40 PM – 3:40 PM ET
Diagnosing and Monitoring Monoclonal Immunoglobulins Using Electrophoresis
Location: PCC 108B
Primary Presenter: A R. Moore, MS, DVM, DACVP – Colorado State University
Oncology
Sponsored by
CE: 1
Wednesday, Jun 14th
3:45 PM – 4:00 PM ET
O01 - Baseline Tumor Gene Expression Signatures Correlate with Chemoimmunotherapy Treatment Responsiveness in Canine B Cell Lymphoma
Location: PCC 108B
Research Abstract - Oral Presenter: Katie Dittrich, VMD – Tufts University Cummings School of Veterinary Medicine
Oncology
Sponsored by
CE: 0.25
Wednesday, Jun 14th
3:50 PM – 4:15 PM ET
Technician Case Report: Clinical Staging for Apocrine Gland Anal Sac Adenocarcinoma in a Dog Resulting in a Diagnosis of Large Cell Lymphoblastic Lymphoma
Location: PCC 108A
Primary Presenter: Amanda Brackett, RVT (she/her/hers) – Canada West Veterinary Specialists
Oncology
Sponsored by
CE: 0.5
Wednesday, Jun 14th
4:00 PM – 4:15 PM ET
O02 - The Immune Landscape of Canine Soft Tissue Sarcomas
Location: PCC 108B
Research Abstract - Oral Presenter: Regina Hayburn, DVM – Colorado State University
Oncology
Sponsored by
CE: 0.25
Wednesday, Jun 14th
4:15 PM – 4:30 PM ET
O03 - Vincristine-Induced Adverse Events as Related to Body Weight in Dogs Treated for Lymphoma
Location: PCC 108B
Research Abstract - Oral Presenter: Keira Sztukowski, DVM (she/her/hers) – The Ohio State University College of Veterinary Medicine
Oncology
Sponsored by
CE: 0.25
Wednesday, Jun 14th
4:30 PM – 4:45 PM ET
O04 - Tolerability and Efficacy of Adjuvant Temozolomide and Doxorubicin Combination Chemotherapy for Canine Splenic Hemangiosarcoma
Location: PCC 108B
Research Abstract - Oral Presenter: Skylar R. Sylvester, DVM, DACVIM (Oncology) (she/her/hers) – Cornell University College of Veterinary Medicine
Oncology
Sponsored by
CE: 0.25
Wednesday, Jun 14th
7:30 PM – 10:00 PM ET
Oncology Specialty Dinner
Location: OFFSITE - Moshulu
Oncology
Sponsored by
Thursday, Jun 15th
10:00 AM – 11:00 AM ET
SOTA: Refining Treatment Paradigms in Oncology through Translational Science
Location: PCC 201AB
SOTA Speaker: Gregory Beatty, MD, PhD – University of Pennsylvania
Oncology
CE: 1
Thursday, Jun 15th
11:15 AM – 12:15 PM ET
Variation in Chemotherapy Administration Guidelines
Location: PCC 204A
Primary Presenter: Brooke W. Quesnell, BS, CVT, VTS (Oncology) – WestVet Emergency and Specialty Center
Oncology
Sponsored by
CE: 1
Thursday, Jun 15th
11:15 AM – 12:15 PM ET
Selecting a Targeted Therapeutic based on Molecular Diagnostics: Pharmacologic and Clinical Path Factors
Location: PCC 201AB
Primary Presenter: G. Sylvester Price, DVM, DACVIM (SAIM & Oncology) – Boehringer Ingelheim
Co-Presenter: Christopher Loss, DVM (he/him/his) – FDA / Center for Veterinary Medicine
Co-Presenter: Douglas H. Thamm, VMD, DACVIM (Oncology) – Colorado State University
Oncology
CE: In-person 1 // On-demand: 0.5
Thursday, Jun 15th
1:45 PM – 2:45 PM ET
Assessment of Biological Aging and Cancer Risk Using Liquid Biopsies
Location: PCC 201C
Primary Presenter: Kelly M. Makielski, DVM, MS, DACVIM (SAIM) (she/her/hers) – University of Minnesota
Oncology
Sponsored by
CE: 1
Thursday, Jun 15th
3:00 PM – 4:00 PM ET
Pain Management in Cancer Patients
Location: PCC 204A
Primary Presenter: Brooke W. Quesnell, BS, CVT, VTS (Oncology) – WestVet Emergency and Specialty Center
Oncology
Sponsored by
CE: 1
Thursday, Jun 15th
3:00 PM – 4:00 PM ET
Panel Discussion: Selecting a Targeted Therapeutic based on Molecular Diagnostics
Location: PCC 201C
Primary Presenter: G. Sylvester Price, DVM, DACVIM (SAIM & Oncology) – Boehringer Ingelheim
Co-Presenter: Christopher Loss, DVM (he/him/his) – FDA / Center for Veterinary Medicine
Co-Presenter: Douglas H. Thamm, VMD, DACVIM (Oncology) – Colorado State University
Oncology
CE: 1
Thursday, Jun 15th
4:30 PM – 5:15 PM ET
Opportunities and Challenges of Genomics-guided Targeted Therapy in Dogs with Cancer
Location: PCC 201C
Primary Presenter: Lucas Rodrigues, DVM, PhD – FidoCure
Co-Presenter: Gerry Post, DVM, MEM, DACVIM (Oncology) (he/him/his) – FidoCure
Oncology
CE: 0.5
Thursday, Jun 15th
5:15 PM – 6:00 PM ET
Repurposed Medicine in Oncology: New Approaches with Old Drugs
Location: PCC 201C
Primary Presenter: Barbara E. Kitchell, DVM, PhD, DACVIM (SAIM & Oncology (she/her/hers) – VCA
Oncology
CE: 1
Friday, Jun 16th
8:00 AM – 9:00 AM ET
Electroporation: How to Beat Cancer by Opening the Cell: ECT and GET
Location: PCC 201C
Primary Presenter: Dr .Joseph Impellizeri, DVM, DACVIM (Oncology), MRCVS – Veterinary Oncology Services
Oncology
CE: 1
Friday, Jun 16th
9:15 AM – 10:15 AM ET
The Dog Aging Project: Early Cancer Findings
Location: PCC 201C
Primary Presenter: Kate E. Creevy, DVM, MS, DACVIM (SAIM) (she/her/hers) – Texas A&M University
Oncology
Sponsored by
CE: 1
Friday, Jun 16th
11:00 AM – 12:00 PM ET
Understanding Tumor Behavior Starts with Standardized Methods
Location: PCC 201C
Primary Presenter: Don Meuten, DVM, PhD – NCSU OSU TAMU ROSS LMU Cornell
Co-Presenter: Taryn A. Donovan, DVM, DACVP (she/her/hers) – Schwarzman Animal Medical Center
Oncology
CE: 1
Friday, Jun 16th
1:30 PM – 2:00 PM ET
Frequency of Cancer Following Screening in Higher Risk, Middle-Aged to Older Dogs
Location: PCC 201C
Research Report Presenter: Jenna H. Burton, DVM, MS, DACVIM (Oncology) (she/her/hers) – Colorado State University, Flint Animal Cancer Center
Oncology
CE: 0.5
Friday, Jun 16th
2:00 PM – 2:30 PM ET
The Integrated Canine Data Commons (ICDC): Two Year Experience Report
Location: PCC 201C
Research Report Presenter: Amy K. LeBlanc, DVM, DACVIM (Oncology) – NIH/NCI/CCR Comparative Oncology Program
Oncology
CE: 0.5
Friday, Jun 16th
2:45 PM – 3:00 PM ET
O05 - Tolerability Evaluation of Combination Verdinexor (LAVERDIA-CA1) and Doxorubicin in Tumor-bearing Dogs
Location: PCC 201C
Research Abstract - Oral Presenter: Joelle M. Fenger, DVM, PhD, DACVIM (Oncology) (she/her/hers) – Ethos Discovery, Ethos Veterinary Health
Oncology
CE: 0.25
Friday, Jun 16th
3:00 PM – 3:15 PM ET
O06 - Tumour Necrosis Factor Stimulated Gene 6 Intrinsically Regulates PD-L1 Expression, Modulating the Breast Cancer Microenvironment.
Location: PCC 201C
Research Abstract - Oral Presenter: Jeong-Hwa Lee, DVM – Seoul National University
Oncology
CE: 0.25
Friday, Jun 16th
3:15 PM – 3:30 PM ET
O07 - Kynurenine 3-monooxygenase and ki67 Are Effective Biomarkers for Canine Cancer Diagnosis
Location: PCC 201C
Research Abstract - Oral Presenter: Chen-Si Lin, DVM, PhD – National Taiwan University
Oncology
CE: 0.25
Friday, Jun 16th
3:30 PM – 3:45 PM ET
O08 - Genome-wide CRISPR Knockout Screening Identifies Candidate Molecular Targets for Canine Oral Melanoma
Location: PCC 201C
Research Abstract - Oral Presenter: Nick J. Parkinson, MA, MS, VetMB, PhD, CertEM(Int Med), DACVIM (LAIM), MRCVS (he/him/his) – University of Edinburgh
Oncology
CE: 0.25
Friday, Jun 16th
4:30 PM – 4:45 PM ET
O09 - Patient Outcomes When Liquid Biopsy Was Used as an Aid in Diagnosis for Cancer
Location: PCC 201C
Research Abstract - Oral Presenter: Allison L. O'Kell, DVM, MS, DACVIM (SAIM) – PetDx
Oncology
CE: 0.25
Friday, Jun 16th
4:30 PM – 6:00 PM ET
A Team Approach to Surgical Oncology
Location: PCC 204A
Primary Presenter: Jenny Fisher, RVT, VTS (Oncology) (she/her/hers) – PractiVet
Co-Presenter: Garrett Levin, Diplomate ACVS (he/him/his) – Ascend Veterinary Surgery, PLLC
Oncology
Sponsored by
CE: 1.5
Friday, Jun 16th
4:45 PM – 5:00 PM ET
O10 - Evaluation of a Next-generation Sequencing-based Liquid Biopsy Test for Cancer Monitoring in Dogs
Location: PCC 201C
Research Abstract - Oral Presenter: Andi Flory, DVM, DACVIM (Oncology) (she/her/hers) – PetDx
Oncology
CE: 0.25
Friday, Jun 16th
5:00 PM – 5:15 PM ET
O11 - Neutropenia-induced Adverse Events Following CCNU with or Without Prophylactic Antibiotics in Dogs
Location: PCC 201C
Research Abstract - Oral Presenter: Emily J. Rawlings, DVM (she/her/hers) – University of Minnesota
Oncology
CE: 0.25
Friday, Jun 16th
5:15 PM – 5:30 PM ET
O12 - Single-Cell Analysis of Natural Killer Cells in Response to Immunotherapy in First-in-Dog Clinical Trials
Location: PCC 201C
Research Abstract - Oral Presenter: Aryana Razmara, MS – UC Davis
Oncology
CE: 0.25
Friday, Jun 16th
5:30 PM – 5:45 PM ET
O13 - Clinico-genomics Analysis of Canine Anal Sac Adenocarcinoma: Genomic Profile and Treatment Opportunity
Location: PCC 201C
Research Abstract - Oral Presenter: Lucas Rodrigues, DVM, PhD – FidoCure
Oncology
CE: 0.25
Friday, Jun 16th
5:45 PM – 6:00 PM ET
O14 - Mutation Landscape and Clinical Actionability in Canine Osteosarcoma
Location: PCC 201C
Research Abstract - Oral Presenter: William Hendricks, PhD (he/him/his) – Vidium Animal Health
Oncology
CE: 0.25
Saturday, Jun 17th
8:00 AM – 9:00 AM ET
Bisphosphonate Use in Companion Animal Medicine
Location: PCC 201C
Primary Presenter: Brian Flesner, DVM, MS, DACVIM (Oncology) (he/him/his) – n/a
Oncology
CE: 1
Saturday, Jun 17th
9:10 AM – 10:10 AM ET
What's New in Veterinary Oncology
Location: PCC 204A
Primary Presenter: Craig A. Clifford, DVM, DACVIM (Oncology) (he/him/his) – BluePearl
Co-Presenter: Christine M. Mullin, VMD, DACVIM (Oncology) (she/her/hers) – BluePearl
Oncology
Sponsored by
CE: 1
Saturday, Jun 17th
9:10 AM – 10:10 AM ET
The Genomic Landscape of Metastatic Canine Osteosarcoma
Location: PCC 201C
Primary Presenter: Heather Gardner, DVM, PhD, DACVIM (Oncology) – Cummings School of Veterinary Medicine-Tufts
Oncology
CE: 1
Saturday, Jun 17th
10:20 AM – 11:20 AM ET
Canine Cutaneous and Oral Melanocytic Tumors: Current Diagnostic and Prognostic Strategies
Location: PCC 201C
Primary Presenter: Rebecca Smedley, DVM, MS, DACVP (she/her/hers) – Michigan State Univ, CVM, Veterinary Diagnostic Laboratory
Oncology
CE: 1
Saturday, Jun 17th
11:30 AM – 12:30 PM ET
Two Years of Liquid Biopsy Testing in Dogs
Location: PCC 201C
Primary Presenter: Andi Flory, DVM, DACVIM (Oncology) (she/her/hers) – PetDx
Oncology
Sponsored by
CE: 1
Wednesday, Jun 28th
10:00 AM – 11:00 AM ET
New Treatment Options in Canine Lymphoma
Primary Presenter: Craig A. Clifford, DVM, DACVIM (Oncology) (he/him/his) – BluePearl
Oncology
Sponsored by
CE: 1
Wednesday, Jun 28th
11:20 AM – 12:20 PM ET
Transcriptomic & Genetic Profiling of Canine Oral Melanoma to Understand Metastasis
Primary Presenter: Kelly Blacklock, BVMS, PGCert, PhD, DECVS, SFHEA, FRCVS – University of Edinburgh
Oncology
CE: 1
Wednesday, Jun 28th
12:40 PM – 1:40 PM ET
Immunohistochemistry Applications in Feline Patients
Primary Presenter: Ann Hohenhaus, DVM, DACVIM (SAIM & Oncology) (she/her/hers) – Schwarzman Animal Medical Center
Oncology
CE: 1
Wednesday, Jun 28th
3:20 PM – 4:20 PM ET
Hematopoietic Cell Transplantation for the Treatment of Canine Lymphoma
Primary Presenter: Steven E. Suter, DACVIM (Oncology), MS, PhD (he/him/his) – North Carolina State University College of Veterinary Medicine
Oncology
CE: 1
Wednesday, Jun 28th
3:20 PM – 4:20 PM ET
Paraneoplastic Syndromes
Primary Presenter: Danielle D. DeCormier, LVT, VTS (Oncology), CFE (she/her/hers) – MedVet
Oncology
Sponsored by
CE: 1
Wednesday, Jun 28th
4:40 PM – 5:40 PM ET
Pain Management for the Cancer Patient
Primary Presenter: Michael W. Nolan, DVM, PhD, DACVR (RO) (he/him/his) – North Carolina State University
Oncology
CE: 1
Wednesday, Jun 28th
6:00 PM – 7:00 PM ET
Cutaneous Canine Mast Cell Tumors: Is Cytology Up to Grade?
Primary Presenter: Paula M. Krimer, DVM, DVSc, DACVP (Clinical Pathology) (she/her/hers) – IDEXX BioAnalytics
Co-Presenter: Taryn A. Donovan, DVM, DACVP (she/her/hers) – Schwarzman Animal Medical Center
Oncology
CE: 1